Option Care Health

Option Care Health
Name	Option Care Health
Type	Public
Industry	Healthcare
Founded	1994
Headquarters	Downers Grove, Illinois, United States
Area served	United States
Key people	Michael J. Vescera (President, CEO)
Revenue	$4.1 billion (2023)
Num employees	15,000+

Option Care Health Option Care Health is an American provider of home and alternate-site infusion services operating across the United States, delivering infusion therapy, nutrition, and support to patients in home, ambulatory, and long-term care settings. The company participates in healthcare delivery networks, interacts with insurers and pharmacy benefit managers, and competes with national providers in the post-acute care and specialty pharmacy markets. Its operations intersect with federal programs, private payers, and hospital systems as it expands services and infrastructure.

History

Option Care Health traces origins to a series of corporate formations and consolidations in the home infusion and pharmacy sectors that involved private equity firms and strategic investors. Its predecessors and affiliates engaged with entities such as Walgreens Boots Alliance, Omnicare-affiliated companies, and regional providers in waves of consolidation during the 1990s and 2000s. The firm’s corporate trajectory reflects wider trends seen with companies like CVS Health, UnitedHealth Group, McKesson Corporation, and Cardinal Health as national chains and distributors sought scale in outpatient infusion and specialty services. Public filings and market moves mirrored sector activity exemplified by transactions involving Thermo Fisher Scientific and restructurings akin to those at DaVita and Kindred Healthcare.

Services and Care Programs

Option Care Health provides clinically managed infusion therapy, enteral nutrition, injectable biologics, and specialty pharmacy services, interfacing with hospitals, physician practices, and long-term care facilities such as Mayo Clinic, Cleveland Clinic, and regional health systems. Its care models include complex home infusion for conditions treated with drugs like monoclonal antibodies used in oncology and autoimmune disease, therapies comparable to regimens delivered by centers such as MD Anderson Cancer Center and Fred Hutchinson Cancer Center. The company integrates with electronic health record platforms from vendors like Epic Systems Corporation, telehealth technologies similar to offerings by Teladoc Health and Amwell, and collaborates with laboratory services that echo partnerships seen with LabCorp and Quest Diagnostics. Case management and patient support programs draw on nurse networks and clinical protocols paralleling those at Johns Hopkins Medicine and Massachusetts General Hospital.

Corporate Structure and Leadership

Option Care Health operates under a corporate governance model with a board of directors and executive leadership responsible for strategic planning, compliance, and operations. Executives draw experience from organizations such as Express Scripts, AmerisourceBergen, Pfizer, and Johnson & Johnson; board affiliations and prior roles often include positions at companies like Allscripts and institutions such as Harvard Business School. The corporate structure includes regional operating divisions and clinical leadership teams that mirror organizational designs used by Sunrise Senior Living and national health systems like Kaiser Permanente for scale and quality oversight.

Mergers, Acquisitions, and Financial Performance

Option Care Health’s growth strategy has relied on mergers and acquisitions, including transactions reminiscent of deals executed by Humana, Cigna, and private equity activity involving firms like TPG Capital and KKR. The company has pursued roll-ups of regional infusion providers to increase market share against competitors like BioScrip and Coram CVS Specialty, while navigating reimbursement dynamics influenced by the Centers for Medicare & Medicaid Services and policy shifts similar to those affecting Medicare Part B billing. Financial performance metrics, revenue trends, and stock movements align with patterns seen in publicly traded healthcare services companies and have been compared with peers such as Laboratory Corporation of America.

Quality, Regulation, and Accreditation

Option Care Health is subject to regulatory oversight and accreditation standards from bodies comparable to The Joint Commission, Community Health Accreditation Partner, and state departments of health. Compliance areas include sterile compounding standards influenced by guidance from United States Pharmacopeia chapters, patient safety protocols paralleling Institute for Healthcare Improvement initiatives, and adherence to billing and documentation rules under statutes enforced by Office of Inspector General (United States Department of Health and Human Services). The company engages in quality improvement programs and reporting that reflect practices adopted by national healthcare organizations such as Agency for Healthcare Research and Quality and academic quality collaboratives.

Controversies and Legal Issues

Option Care Health has faced litigation, reimbursement disputes, and regulatory inquiries similar to those involving other large healthcare services firms such as McKesson and Omnicare, including contested claims over billing practices, contractual disagreements with payers like Aetna and Blue Cross Blue Shield Association, and audits by agencies comparable to Centers for Medicare & Medicaid Services. Legal matters have encompassed allegations connected to prior authorization processes and coding, echoing enforcement actions seen in cases with firms such as Laboratory Corporation of America and Quest Diagnostics. The company’s legal history involves settlements, appeals, and compliance remediation efforts that parallel industry responses to federal and state investigations.

Category:Health care companies based in Illinois Category:Pharmacies of the United States